Cleared Traditional

K172285 - Ablatherm Fusion (FDA 510(k) Clearance)

Oct 2017
Decision
67d
Days
Class 2
Risk

K172285 is an FDA 510(k) clearance for the Ablatherm Fusion. This device is classified as a High Intensity Ultrasound System For Prostate Tissue Ablation (Class II - Special Controls, product code PLP).

Submitted by Edap Technomed, Inc. (Austin, US). The FDA issued a Cleared decision on October 3, 2017, 67 days after receiving the submission on July 28, 2017.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.4340. Prostate Tissue Ablation.

Submission Details

510(k) Number K172285 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2017
Decision Date October 03, 2017
Days to Decision 67 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PLP - High Intensity Ultrasound System For Prostate Tissue Ablation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.4340
Definition Prostate Tissue Ablation